Novartis gets breakthrough designation for Xolair successor, setting up spotlight for PhIII readout ...

Retrieved on: 2021-01-14 16:32:35

Tags for this article:

Click the tags to see associated articles and topics

Novartis gets breakthrough designation for Xolair successor, setting up spotlight for PhIII readout .... View article details on hiswai:

Excerpt

With its Roche-partnered Xolair no longer under patent protection, Novartis and CEO Vas Narasimhan are looking for the next drug up to step into the ...

Article found on: endpts.com

View Original Article